If you’ve been waiting for an Omnilux sale to see what all the hype around LED masks is about, you’re in luck. In honor of Valentine’s Day, the brand is offering $50 off one mask, $115 off two masks ...
According to the Sleep Apnea Association, “CPAP dermatitis is a type of skin irritation or rash caused by using a CPAP ...
The Shark CryoGlow boasts a range of features that differentiate it from other LED masks on the market, from an integrated cooling under-eye treatment to its four preset modes and easy-to-use remote.
Even though many CGM users still need test strips for calibration or backup, insurers are cutting quantities dramatically. Some plans now limit strips to as few as 10 per month, regardless of your ...
REMSleep says the final pieces of its commercial strategy for the DeltaWave nasal pillow system are falling into place as the company prepares for a broader market push.
ResMed’s fourth quarter performance drew a positive market reaction, with management attributing the outperformance to strong global demand for its masks and devices, as well as continued growth in ...
This one is for investors seeking quality, global reach, and durable earnings. The post 3 reasons to buy this heavyweight ASX ...
We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls ...
Resmed Inc () has held its Q2 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium. Unlock hedge fund-level data and powerful investing tools ...
Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, Canada and ...
Medical device company ResMed (NYSE:RMD) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 11% year on year to $1.42 billion. Its non-GAAP profit of $2.81 per share ...
Q2 FY2026 earnings call recap: 11% revenue growth, margin expansion, AI innovation, and updated 62–63% guidance—read key takeaways now.